Oncology Strategy Meeting, San Diego 2021

Oncology

Strategy Meeting, San Diego 2021

We’re bringing the Oncology Strategy Meeting to San Diego. Discuss key issues with your peers, catch up with the latest technologies and forge those all important partnerships. Unlike typical conferences, the Proventa International Strategy Meeting format is interactive and informal, where industry leaders can share insight and explore new partnerships.

27th May 2021
The Westin San Diego Gaslamp Quarter

Strategy Meetings

Transforming the way we network

Often at conferences, seminars and summits you are placed amongst a large pool of industry professionals, however the opportunity to share personal insights and knowledge is limited. With Proventa International’s unique format of executive roundtables, you are placed side by side with those same industry leaders, in private, facilitated discussions on pre-selected topics.

Strategy Meetings

What makes our strategy meetings unique?

No other event creates such a unique and personalised event experience. From the tailored agenda, to the senior delegation to central venues; our strategy meetings provide the perfect learning and networking environment.

Roundtable Discussions

Intimate discussions lead by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech. Join in the roundtables, set-up private meetings or introduce yourself over drinks.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Great Food and Drinks

What event would be complete without great catering? Enjoy breakfast, a delicious lunch and finish the day with drinks and canapés.

Meet the Facilitators

Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the 2021 Strategy Meeting:

Andreas Bader

Senior Vice President of R&D Triumvira Immunologics

Tahira Khan

Senior Director, Regulatory Affairs Nektar Therapeutics

Elena Brin

CSO & CEO Athae Bio

Erin Filbert

Associate Director – Immuno-Oncology Research Apexigen

Angus Sinclair

Vice President Oncology IGM Biosciences

Sudhir Sahasrabudhe

CSO/CEO JSK Therapeutics

Reid Bissonnette

Vice President, Immuno-Oncology TargaZyme, Inc.

Majid Ghoddusi

Executive Director, Clinical Biomarker Poseida Therapeutics

Michael A. Damore

Head Translational Oncology Lead Pfizer

Christopher Bond

SVP Pre-Clinical & Translational Sciences Notch Therapeutics

Charles Theuer

President & CEO TRACON Pharmaceuticals

<p>Dr. Theuer has served as President, Chief Executive Officer and a member of the board of directors of TRACON Pharmaceuticals since July 2006. From 2004 to 2006, Dr. Theuer was the Chief Medical Officer and Vice President of Clinical Development at TargeGen, Inc., a biotechnology company, where he led the development of small molecule kinase inhibitors in oncology, ophthalmology and cardiovascular disease. Prior to joining TargeGen, Inc., Dr. Theuer was Director of Clinical Oncology at Pfizer, Inc., a pharmaceutical corporation, from 2003 to 2004. At Pfizer, Dr. Theuer led the clinical development of Sutent® in kidney cancer; Sutent® was approved by the U.S. Food and Drug Administration in 2006 for the treatment of advanced kidney cancer. Dr. Theuer has also held senior positions at IDEC Pharmaceuticals Corp. from 2002 to 2003 and at the National Cancer Institute from 1991 to 1993. In addition, he has held academic positions at the University of California, Irvine, where he was Assistant Professor in the Division of Surgical Oncology and Department of Medicine. Dr. Theuer received a B.S. from the Massachusetts Institute of Technology, an M.D. from the University of California, San Francisco, and a Ph.D. from the University of California, Irvine. He completed a general surgery residency program at Harbor-UCLA Medical Center and was board certified in general surgery in 1997.  Dr. Theuer’s previous research involved immunotoxin and cancer vaccine development, translational work in cancer patients, and gastrointestinal cancer epidemiology.</p>

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution

Agenda